D.E. Shaw & Co’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

D.E. Shaw & Co’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200,000	Closed	-$2.09M	–	4790
2023 Q1	$2.09M	Hold	200,000	–	–	﹤0.01%	2663
2022 Q4	$2.06M	Hold	200,000	–	–	﹤0.01%	2922
2022 Q3	$2.01M	Hold	200,000	–	–	﹤0.01%	3005
2022 Q2	$1.99M	Hold	200,000	–	–	﹤0.01%	3083
2022 Q1	$2M	Buy	+200,000	New	+$1.99M	﹤0.01%	3298

D.E. Shaw & Co's LVAC Position: Q2 2023 in Review

D.E. Shaw & Co sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 200,000 shares — an estimated $2.09M sold.

D.E. Shaw & Co first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $2.09M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

D.E. Shaw & Co reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 200,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.09M.
D.E. Shaw & Co first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
D.E. Shaw & Co's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.09M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.